also(passive) may ... be causedDisorders of lipid metabolism
severe hyper - TGmay causedisorders in the lipid metabolism
that mutated coding for carnitine - acylcarnitine translocasecausesinborn lipid metabolism disorders
mutated coding for carnitine - acylcarnitine translocasecausesinborn lipid metabolism disorders
by diabetes(passive) caused byabnormal lipid metabolism
to hyperuricemialeadto hyperuricemia
abnormally elevated levels of cholesterol ( TC ) , triglycerides ( TG ) and lipoproteins in the bloodcausesabnormally elevated levels of cholesterol ( TC ) , triglycerides ( TG ) and lipoproteins in the blood
morbidity and mortalityresultsmorbidity and mortality
in high triglyceride and LDL concentrations ... and low levels of HDL in the bloodresultsin high triglyceride and LDL concentrations ... and low levels of HDL in the blood
from absent or deficient expression of pyruvate carboxylase activityresultingfrom absent or deficient expression of pyruvate carboxylase activity
to diseases including obesity , diabetes , lipidemia , hepatic lipidosis , and so oncan leadto diseases including obesity , diabetes , lipidemia , hepatic lipidosis , and so on
abnormal lipid content in the bloodcausesabnormal lipid content in the blood
the most common disease of cardiovascular disease , namely atherosclerosiscausesthe most common disease of cardiovascular disease , namely atherosclerosis
to decreasedleadsto decreased
to decreased high - density lipoprotein ( hdl ) and increasedleadsto decreased high - density lipoprotein ( hdl ) and increased
to diseases such as hyperlipidemia , insulin resistance , diabetes and fatty livercan leadto diseases such as hyperlipidemia , insulin resistance , diabetes and fatty liver
diseases(passive) caused bydiseases
to hyperlipidemia that triggers atherosclerosiscan leadto hyperlipidemia that triggers atherosclerosis
in adultscan causein adults
to cardiovascular diseasescan leadto cardiovascular diseases
two genetic diseases(passive) caused bytwo genetic diseases
29 Bone marrow fat cell(passive) caused by29 Bone marrow fat cell
in extravascular lipid deposition and elevated intraosseous pressureresultedin extravascular lipid deposition and elevated intraosseous pressure
the initiation and progression of atherosclerotic vascular changescausethe initiation and progression of atherosclerotic vascular changes
causes or comorbidities in a variety of diseases including hyperlipidemia , pancreatitis , type 2 diabetes and atherosclerosisare contributingcauses or comorbidities in a variety of diseases including hyperlipidemia , pancreatitis , type 2 diabetes and atherosclerosis
in very high LDL cholesterol levels in the bloodmay resultin very high LDL cholesterol levels in the blood
to the development and progression of diseases such as arteriosclerosis , diabetes , cancer , inflammatory conditions , pain and neurodegenerative diseasescontributeto the development and progression of diseases such as arteriosclerosis , diabetes , cancer , inflammatory conditions , pain and neurodegenerative diseases
to steatohepatitis in diabetescontributingto steatohepatitis in diabetes
to steatohepatitiscontributingto steatohepatitis
variable clinical presentations , often involving skeletal muscle , alone or together with other tissuescan causevariable clinical presentations , often involving skeletal muscle , alone or together with other tissues
in an increased risk for atherosclerosis and that lowering of LDL - cholesterol and postprandial lipoproteins reduces morbidity and mortality from CHDresultin an increased risk for atherosclerosis and that lowering of LDL - cholesterol and postprandial lipoproteins reduces morbidity and mortality from CHD
to health conditions such as hyperlipidaemia , diabetes , obesity and cardiovascular diseases which increase the risk of further health implicationscan leadto health conditions such as hyperlipidaemia , diabetes , obesity and cardiovascular diseases which increase the risk of further health implications